Sino-Life Group Limited (8296) AI Stock Analysis

Sino-Life Group Limited

(HKEX:8296)

Select Model

Rating:48Neutral

Price Target:HKD 0.19▲(1.58% Upside)

Action:reiterated

Date:10/21/26

The score is held down primarily by weak financial performance (persistent losses, recent revenue decline, and negative operating/free cash flow). Technicals provide some offset with short-term momentum, but the extremely overbought RSI and price below the 200DMA add risk. Valuation is also constrained by a negative P/E and no dividend yield data.

Positive Factors

Moderate LeverageThe lower debt-to-equity ratio indicates reduced balance-sheet strain compared with earlier years. Moderate leverage can preserve financial flexibility and reduce obligations that compete with operating investment, although this benefit depends on the company stabilizing losses and cash generation.

Negative Factors

Persistent Net LossesRecurring net losses indicate that the current business model has not converted revenue and gross profit into sustainable shareholder returns. Continued losses can weaken the equity base over time, constrain reinvestment, and make a durable recovery dependent on meaningful operational improvement.

Sino-Life Group Limited (8296) vs. iShares MSCI Hong Kong ETF (EWH)

Market Cap: HKD 18.43M
Dividend Yield: ―
Average Volume (3M): 20.23K
Price to Earnings (P/E): -0.8
Beta (1Y): -0.22
Revenue Growth: -26.00%
EPS Growth: -188.55%
Country: Hong Kong
Employees: 134
Sector: Consumer Cyclical
Sector Strength: 61
Industry: Personal Products & Services

Sino-Life Group Limited Business Overview & Revenue Model

Company Description

Sino-Life Group Limited, an investment holding company, provides funeral and related services in the People’s Republic of China, Taiwan, Hong Kong, and Vietnam. It operates in two segments, Funeral Services; and Biotechnical and other businesses. The...

Sino-Life Group Limited Financial Statement Overview

Summary

Overall fundamentals are weak. The company has persistent net losses, recent revenue contraction (~18% in 2025), and renewed cash burn with negative operating and free cash flow in 2023–2025. The balance sheet is comparatively steadier with moderate leverage and improved debt-to-equity, but ongoing losses and cash outflows remain the dominant risk.

Income Statement

34Negative

Balance Sheet

63Positive

Cash Flow

28Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	39.34M	64.38M	74.94M	72.57M	77.97M	72.86M
Gross Profit	14.02M	30.95M	32.28M	33.48M	39.80M	37.98M
EBITDA	-12.06M	-2.37M	174.00K	1.70M	17.78M	-4.28M
Net Income	-16.47M	-6.56M	-8.70M	-7.17M	-847.00K	-9.87M
Balance Sheet
Total Assets	207.59M	229.53M	250.63M	271.71M	284.79M	263.85M
Cash, Cash Equivalents and Short-Term Investments	127.48M	133.16M	148.63M	173.51M	180.59M	156.13M
Total Debt	19.29M	21.79M	29.68M	37.43M	27.90M	33.49M
Total Liabilities	121.75M	131.29M	147.09M	163.17M	153.97M	158.27M
Stockholders Equity	109.17M	120.42M	123.45M	123.72M	113.22M	114.61M
Cash Flow
Free Cash Flow	-2.91M	-6.22M	-8.97M	-3.04M	7.77M	-4.31M
Operating Cash Flow	-2.91M	-4.85M	-8.21M	-2.60M	10.24M	-407.00K
Investing Cash Flow	2.77M	2.08M	-3.30M	17.36M	-32.20M	-1.83M
Financing Cash Flow	-2.09M	-7.40M	-2.10M	-7.66M	18.77M	-7.75M

Sino-Life Group Limited Technical Analysis

Technical Analysis SentimentNeutral

Last Price0.19

Price Trends

50DMA0.16Positive

100DMA0.17Positive

200DMA0.24Negative

Market Momentum

MACD0.01Negative

RSI72.09Negative

STOCH78.97Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8296, the sentiment is Neutral. The current price of 0.19 is above the 20-day moving average (MA) of 0.18, above the 50-day MA of 0.16, and below the 200-day MA of 0.24, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 72.09 is Negative, neither overbought nor oversold. The STOCH value of 78.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:8296.

Sino-Life Group Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

HK:8296 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:1830	68Neutral	HKD 1.43B	8.01	43.78%	12.76%	-14.68%	-13.60%
Sector *	61Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
HK:1448	56Neutral	HKD 6.03B	14.00	6.50%	20.98%	―	―
HK:0922	52Neutral	HKD 208.81M	-1.80	-13.22%	17.02%	-16.99%	-326.96%
HK:2521	52Neutral	HKD 1.80B	49.26	6.47%	―	2.78%	-41.23%
HK:0919	50Neutral	HKD 67.84M	-37.50	-0.93%	―	-2.31%	66.07%
HK:8296	48Neutral	HKD 17.95M	-0.76	-17.95%	―	-26.00%	-188.55%

* Consumer Cyclical Sector Average

Performance Comparison

HK:8296 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
HK:8296	Sino-Life Group Limited	0.19	-0.19	-50.00%
HK:1448	Fu Shou Yuan International Group	2.64	-0.25	-8.69%
HK:0919	Modern Healthcare Technology Holdings Limited	0.07	0.00	4.17%
HK:0922	Anxian Yuan China Holdings Limited	0.09	-0.06	-37.33%
HK:1830	Perfect Medical Health Management Limited	1.14	-0.08	-6.79%
HK:2521	Shenghui Cleanness Group Holdings Limited	0.93	0.53	131.25%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 21, 2026

Sino-Life Group Limited AI Stock Analysis